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Abstract
Angiogenesis is the growth of new blood vessels and is a key process which occurs during both
physiological and pathological disease processes. Knowledge of the mechanisms through which this
process is initiated and maintained will have a significant impact on the treatment of these diseases.
Pathological angiogenesis occurs in major diseases such as cancer, diabetic retinopathies, age-
related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial
infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher
morbidity and mortality.
Editorial
The concept of tumor angiogenesis and therapy was pro-
posed by Dr. Judah Folkman, who published the first and
probably one of the most cited articles in 1971 [1]. In that
article, Folkman showed and discussed early evidence that
solid tumors could not grow beyond several millimetres
in diameter without blood vessels and they might be held
at the nonvascularized dormant stage. He proposed that
tumors produce soluble factors to stimulate vessel growth
and inhibition of tumor angiogenesis might be a novel
approach for cancer therapy. While this hypothesis
sounds logical and reasonable now, Folkman experienced
unusually unsympathetic criticisms from his colleagues at
that time. It took him nearly 30 years to convince the sci-
entific community that his hypothesis was the correct one.
We are all very grateful for Dr. Folkman's persistence,
which has opened one of the most exciting and fast-
expanding research areas in biomedical research. Today,
millions of patients suffering from cancer and non-malig-
nant diseases receive anti-angiogenic therapy. For those
who work in this field, we are extremely fortunate to see
Dr. Folkman's extraordinary achievements that have
changed not only our lives but millions of patients.
Over the last couple of decades scientists have identified
the importance of angiogenesis in determining disease
development in association with tissue remodelling. It is
now established that therapeutic modulation of the "ang-
iogenic switch", may be a key mechanism for the treat-
ment of these diseases. For these reasons and due to the
continual expansion of this area of biomedical research,
we are proud to announce the launch of Journal of Angio-
genesis Research.
Journal of Angiogenesis Research aims to publish articles
from all areas of the 'broad spectrum' of vascular research
and from the bench to the bed-side. All submitted articles
will be screened initially by a member of the journal's Edi-
torial Board and if found to be suitable will be sent out for
peer-review to internationally recognised experts in the
field of angiogenesis research. The journal aims for the
review process to be rapid and once accepted, the manu-
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BioMedcentral
scripts will be published online immediately in a provi-
sional format. Once an article is accepted for publication,
the publisher will levy an Article Processing Charge which
is a flat rate fee used to cover the article handling costs.
Since articles are published online, there are no restric-
tions on size and number of figures that can be included.
Articles will be immediately submitted to public reposi-
tories and will be freely available to read or down-load to
readers world-wide.
Accepted articles will be of the highest quality and can
take the form of original research articles, reviews and
commentaries (some commissioned) providing perti-
nent, cutting edge up-dates in a focussed area of research.
These can be in any field of research related to angiogen-
esis, from identification of novel mechanisms and signal-
ling factors associated with angiogenesis, in vitro and in
vivo disease models, results from pre-clinical trials, novel
imaging modalities and nano-biological approaches.
Please see the journal website for a more complete list of
topics [2].
Journal of Angiogenesis Research welcomes your submis-
sions, and hopes you will visit the website often to stay
up-to-date with the latest articles.
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